Sunday, 03 July 2022



LATEST NEWS Shri Gou Gopal Paryavaran Sammelan Police arrests 02 notorious drug peddlers in Pulwama Police Hospital Jammu celebrated National Doctor's Day One month Re-Orientation Course" for all In-Charge M.I Rooms of Armed & IR Battalions of Jammu province concludes Mansukh Mandaviya to Pharma Industry: Time to move from ‘Volume’ to “Value’ leadership to capture global market Dr. Jitendra Singh calls for promoting StarUps in "carbon neutral" building construction and linking them with industry to help India achieve 500GW non-fossil energy capacity by 2030 Dharmendra Pradhan visits IIT Hyderabad, inaugurates a slew of facilities for strengthening research, innovation and entrepreneurship Rajnath Singh dedicates to the nation new manufacturing facilities at Bharat Dynamics Limited, Bhanur Minister Rajeev Chandrasekhar visits UK PM Boris Johnson along with Startups, Unicorn Heads from India NITI Aayog releases ‘Mitigation and Management of COVID-19: Compendium of Ayush-Based Practices from Indian States and Union Territories’ Ram Chandra Prasad Sigh Exhorts NMDC to Enhance Exploration of Minerals using latest Technology and best Industry Practices Ram Chandra Prasad Singh Highlights Immense Possibilities of Utilization of Waste Generated during Mining, Steel Manufacturing Process and end of life products Punjab Chief Minister Bhagwant Mann Launches Honey Coated ‘Corn Flakes’ Produced By Markfed Uorfi Javed Shows Her Injured Neck After Sharing Her Photo In Chain Dress. Says, ‘See The After Effects’ DDC Reasi reviews developmental achievements under Capex Budget plan 2022-23 DDC reviews skill development activities in Rajouri Achieve development targets on time with tangible results on ground: DDC Rajouri DDC reviews drinking water supply scenario in Rajouri Regional Transport Authority approves e- Rickshaw permits Workshop on Establishment of New Fruit Plant Nurseries held at Maralian Horticulture department hosts training for ITI students


US FDA authorises Pfizer booster shots for children aged 5-11 yrs

XE variant, Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Covid-19 Vaccine, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Covifor, Oximeter

Web Admin

Web Admin

5 Dariya News

Los Angeles , 18 May 2022

The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for a booster dose of the Pfizer-BioNTech Covid-19 vaccine for children aged between 5 to 11 years at least five months after completion of the primary vaccine series. On January 3, the FDA authorised on Tuesday the use of a single booster dose of the Pfizer-BioNTech Covid-19 vaccine for individuals aged between 12 to 15 years after completion of primary vaccination. The FDA's decision on Tuesday means anyone aged 5 years and above is now eligible for at least one booster dose, Xinhua news agency reported. "While it has largely been the case that Covid-19 tends to be less severe in children than adults, the Omicron wave has seen more kids getting sick with the disease and being hospitalised, and children may also experience longer term effects, even following initially mild disease," said FDA Commissioner, Robert Califf in a statement. 

"The FDA is authorising the use of a single booster dose of the Pfizer-BioNTech Covid-19 vaccine for children aged between 5 to11 years to provide continued protection against Covid-19," he added. Since authorising the Pfizer-BioNTech Covid-19 vaccine for children aged up to 5 years in October 2021, emerging data suggest that vaccine effectiveness against Covid-19 wanes after the second dose of the vaccine in all authorised populations, said Peter Marks, Director of the FDA's Center for Biologics Evaluation and Research. The FDA said Tuesday's decision is based on analysis of immune response data in a subset of children from the ongoing randomised placebo-controlled trial. Antibody responses were evaluated in 67 study participants, who received a booster dose 7 to 9 months, after completing a two-dose primary series of the Pfizer-BioNTech Covid-19 vaccine. 

The antibody level against the SARS-CoV-2 virus one month after the booster dose was increased compared to before the booster dose, according to the FDA. The FDA has determined that the known and potential benefits of a single booster dose of the Pfizer-BioNTech Covid-19 vaccine for children aged between 5 to 11 years at least five months after completing a primary series outweigh its known and potential risks, and that a booster dose can help provide continued protection against Covid-19 in this and older age groups. Pfizer requested this EUA at the end of April, citing company data which showed that a third vaccine dose raised Omicron-fighting antibodies by 36 times in this age group.


Tags: XE variant , Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Covid-19 Vaccine , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Covifor , Oximeter



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD